Sarah Profitt, PharmD, MMHC, BCOP

Vanderbilt University Medical Center

Sarah Profitt, PharmD, MMHC, BCOP, is a clinical pharmacy specialist in adult malignant hematology at Vanderbilt University Medical Center. Dr. Profitt completed PGY1 pharmacy practice and PGY2 hematology/oncology pharmacy residency training at the University of North Carolina Medical Center and is board certified in oncology pharmacy. Her professional interests include hematologic malignancies, integration and operationalization of novel therapies, health economics and outcomes research, and real-world evidence generation focused on optimizing the safety, effectiveness, and delivery of cancer care. Outside of her clinical responsibilities, Dr. Profitt is an active member of the Hematology Research & Outcomes (HERO) Consortium, the Hematology/Oncology Pharmacy Association (HOPA), and serves as an undergraduate mentor through the University of Tennessee.

Published Articles (1)

Financial Toxicity and Access to Oral Chemotherapy: Prior Authorization, Specialty Pharmacy Steering, and the Importance of Advocacy

October 29, 2026

Prior authorization requirements and specialty pharmacy steering by payors delay the start of oral anticancer therapy, interrupt established treatment and worsen adherence.